Integrated Filing — IndAS

General information about company
Scrip Code	542919
NSE Symbol	ARTEMISMED
MSEI Symbol	NOTLISTED
ISIN	INE025R01021
Name of company	ARTEMIS MEDICARE SERVICES LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	12-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	06-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Healthcare Services
Start date and time of board meeting	12-May-2025   15:30:00
End date and time of board meeting	12-May-2025   16:30:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-02-05
Indicate Company website link for updated RPT policy of the Company	https://www.artemishospitals.com/BackEndImages/downloads/Investorsdata/related-party-transaction-policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	Yes
No. of times funds raised during the quarter	1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
No such default

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	2348013000	9132613000
	Other income	122330000	329150000
	Total income	2470343000	9461763000
2	Expenses
(a)	Cost of materials consumed	574047000	2222236000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	54000
(d)	Employee benefit expense	379993000	1437100000
(e)	Finance costs	75282000	304826000
(f)	Depreciation, depletion and amortisation expense	112482000	430180000
(f)	Other Expenses
1	Other Expenses	1038567000	3974821000
	Total other expenses	1038567000	3974821000
	Total expenses	2180371000	8369217000
3	Total profit before exceptional items and tax	289972000	1092546000
4	Exceptional items	0	0
5	Total profit before tax	289972000	1092546000
6	Tax expense
7	Current tax	37699000	213222000
8	Deferred tax	20227000	44746000
9	Total tax expenses	57926000	257968000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	232046000	834578000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	232046000	834578000
17	Other comprehensive income net of taxes	5013000	-840000
18	Total Comprehensive Income for the period	237059000	833738000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	137602000	137602000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		7595472000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	1.48	5.42
	Diluted earnings (loss) per share from continuing operations	1.47	5.36
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	1.48	5.42
	Diluted earnings (loss) per share from continuing and discontinued operations	1.47	5.36
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		The value of Earning per share for the quarter is not annualised. n nNotes: n n1. The above standalone audited financial results for the quarter and year ended March 31, 2025 (financial results) have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at their respective meetings held on May 12, 2025. The statutory auditors, T R Chadha & Co LLP have expressed an unmodified opinion on the aforesaid financial results. n n2. The above financial results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015, as amended (Ind AS), as prescribed under Section 133 of the Companies Act 2013 (the 'Act') read with the Companies (Indian Accounting Standards) Rules, 2015 (as amended) and the other recognised accounting practices and policies to the extent applicable and is in compliance with presentation and disclosure requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended). n n3. The results for the quarter ended March 31, 2025 and March 31, 2024, are the balancing figures between audited figures in respect of full financial year ended March 31, 2025 and March 31, 2024 respectively and published and unaudited respectively year to date figures up to the third quarter of the respective financial year then ended. n nPlease refer remaining notes from audited financial results filed in PDF format.

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	6398974000
	Capital work-in-progress	387240000
	Investment property	0
	Goodwill	416207000
	Other intangible assets	475892000
	Intangible assets under development	16756000
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	150150000
	Trade receivables, non-current
	Loans, non-current	14817000
	Other non-current financial assets	56330000
	Total non-current financial assets	221297000
	Deferred tax assets (net)
	Other non-current assets	241238000
	Total non-current assets	8157604000
2	Current assets
	Inventories	93339000
	Current financial asset
	Current investments	0
	Trade receivables, current	928588000
	Cash and cash equivalents	410112000
	Bank balance other than cash and cash equivalents	3522512000
	Loans, current	16368000
	Other current financial assets	212603000
	Total current financial assets	5090183000
	Current tax assets (net)
	Other current assets	89927000
	Total current assets	5273449000
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	13431053000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	137602000
	Other equity	8280377000
	Total equity attributable to owners of parent	8417979000
	Non controlling interest
	Total equity	8417979000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	2041235000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
	Total Trade payable
	Other non-current financial liabilities	396404000
	Total non-current financial liabilities	2437639000
	Provisions, non-current	125584000
	Deferred tax liabilities (net)	375001000
	Deferred government grants, Non-current
	Other non-current liabilities
	Total non-current liabilities	2938224000
	Current liabilities
	Current financial liabilities
	Borrowings, current	319197000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	159545000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	812533000
	Total Trade payable	972078000
	Other current financial liabilities	381627000
	Total current financial liabilities	1672902000
	Other current liabilities	261543000
	Provisions, current	140405000
	Current tax liabilities (Net)
	Deferred government grants, Current
	Total current liabilities	2074850000
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	5013074000
	Total equity and liabilites	13431053000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurement gain/(loss) of defined employee benefit plans	5001000	-7915000
2	Deferred Tax adjustment on revaluation that will not be reclassified to profit or loss	1271000	5083000
	Total Amount of items that will not be reclassified to profit and loss	6272000	-2832000
2	Income tax relating to items that will not be reclassified to profit or loss	1259000	-1992000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss
5	Total Other comprehensive income	5013000	-840000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			1092546000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			272250000
	Adjustments for decrease (increase) in inventories			-2396000
	Adjustments for decrease (increase) in trade receivables, current			-115041000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-42991000
	Adjustments for decrease (increase) in other non-current assets			2833000
	Adjustments for other financial assets, non-current			-9727000
	Adjustments for other financial assets, current			-35829000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			87271000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			44529000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			430180000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			14896000
	Adjustments for provisions, non-current			14430000
	Adjustments for other financial liabilities, current			37876000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			1066000
	Adjustments for dividend income			0
	Adjustments for interest income			265261000
	Adjustments for share-based payments			9298000
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			-25395000
	Other adjustments for non-cash items			20382000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			438371000
	Net cash flows from (used in) operations			1530917000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			140129000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			1390788000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			1429000
	Purchase of property, plant and equipment			929895000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			122558000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-3076893000
	Net cash flows from (used in) investing activities	-3882801000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			1742000
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			3300000000
	Proceeds from borrowings			227839000
	Repayments of borrowings			303242000
	Payments of lease liabilities			96624000
	Dividends paid			59755000
	Interest paid			209311000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-91081000
	Net cash flows from (used in) financing activities			2769568000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			277555000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			277555000
	Cash and cash equivalents cash flow statement at beginning of period			132558000
	Cash and cash equivalents cash flow statement at end of period			410113000

Signatory Details
Name of signatory	Sanjiv Kumar Kothari
Designation of person	Chief Financial Officer
Place	Gurugram
Date	12-May-2025